News Releases

News Releases

April 23, 2019 at 8:31 AM EDT

Summary Toggle OptimizeRx to Present at Investor Conferences in May

ROCHESTER, Mich. , April 23, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging platform for the pharmaceutical industry, has been invited to present at three institutional investor conferences in May. Event: Oppenheimer Emerging Growth Conference Date: May

PDF Version
April 8, 2019 at 8:31 AM EDT

Summary Toggle OptimizeRx Expands Investment in Hospitals and Health Systems with Latest Tech and Personnel Adds

Company’s Platform is Technically Integrated with Epic and Cerner, and New Hospital Sales Executive Will Focus on Health System Partnerships ROCHESTER, Mich. , April 08, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging platform for the pharmaceutical

PDF Version
March 20, 2019 at 8:31 AM EDT

Summary Toggle OptimizeRx Survey Shows Providers Want to Engage with Patients on Drug Costs for Adherence and Improved Care

More than 600 providers polled, showing awareness of patients’ increasing drug costs but missed opportunity to support patient financial savings ROCHESTER, Mich. , March 20, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging platform for the pharmaceutical

PDF Version
March 4, 2019 at 8:31 AM EST

Summary Toggle OptimizeRx to Present at the 31st Annual ROTH Conference on March 17-19, 2019; Pre-Conference Webcast Available March 11

ROCHESTER, Mich. , March 04, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging platform for the pharmaceutical industry, has been invited to present at the 31st Annual ROTH Conference being held at The Ritz Carlton, Laguna Niguel in Orange County,

PDF Version
February 26, 2019 at 4:01 PM EST

Summary Toggle OptimizeRx Reports Fourth Quarter 2018 Results; Net Revenue Up 64% to a Record $6.6 Million, Driving First Profitable Year

ROCHESTER, Mich. , Feb. 26, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the fourth quarter and year ended December 31, 2018 . Quarterly comparisons are to the same year-ago quarter.

PDF Version
February 13, 2019 at 8:31 AM EST

Summary Toggle OptimizeRx Sets Fourth Quarter and Full Year 2018 Conference Call for Tuesday, February 26, 2019 at 4:30 p.m. ET

ROCHESTER, Mich. , Feb. 13, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, will hold a conference call on Tuesday, February 26, 2019 at 4:30 p.m. Eastern time to discuss results for the fourth quarter and

PDF Version
February 11, 2019 at 8:31 AM EST

Summary Toggle OptimizeRx Survey Shows Providers Believe They Have a Role in Discussing Care Costs with Patients

ROCHESTER, Mich. , Feb. 11, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, announced today its initial findings from a physician survey focused on prescription drug costs.

PDF Version
February 7, 2019 at 11:30 AM EST

Summary Toggle OptimizeRx Introduces OptimizeMDs, a “Voice of the Physician” Multi-Specialty Digital Health Panel

Panel encourages physicians to provide input on industry efforts to address and improve pharma-to-provider communication ROCHESTER, Mich. , Feb. 07, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has formed

PDF Version
January 29, 2019 at 8:31 AM EST

Summary Toggle OptimizeRx Announces New Partnership with Health IT Pioneer lllumiCare

Partnership to open lines of communication between pharma, providers and patients, supporting financial, clinical and drug education ROCHESTER, Mich. , Jan. 29, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry,

PDF Version
December 18, 2018 at 8:52 AM EST

Summary Toggle OptimizeRx Announces Pricing of Public Offering of Common Stock

ROCHESTER, Mich. , Dec. 18, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced the pricing of the previously announced underwritten public offering by WPP Luxembourg Gamma Three S.à r.l., a

PDF Version

Photograph of the team looking at their EHR services software.

Company

Get the full story on our people, culture and career opportunities.

Photograph of a laptop that is used to look at electronic healthcare records.

Services

Find the specific services now available from OptimizeRx.

Photograph of business partners.

Partners

Explore the many benefits of partnering with OptimizeRx.

Photograph of resources used by healthcare professionals.

Resources

Count on us to help with the information and answers you need.